ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of an experimental drug called DB-1317 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 233 participants to find the safest amount and see if the drug can shrin…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Pfizer tests new 'Smart Bomb' cancer drug in advanced disease patients
Disease control Recruiting nowThis early-stage study is testing the safety and effects of an experimental cancer drug called PF-08046876 in adults with advanced solid tumors. The drug is an antibody drug conjugate designed to target and kill cancer cells. Researchers will give the drug through an IV to about …
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cancer drug combo enters human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis study is testing a new drug called ADG126 in combination with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors that have spread. The main goals are to find the safest and most effective dose and to see if the combination can help control the ca…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Adagene Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Pronged attack on advanced cancer begins human testing
Disease control Recruiting nowThis is a first-in-human study to check the safety and side effects of a new experimental drug called HLX37 in people with advanced or spreading solid tumors, including a type of lung cancer (NSCLC). The drug is designed to block two pathways that help tumors grow. The main goal …
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug shows promise in early trials for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called SYS6043 in people with advanced solid tumors that have spread or returned after standard treatments. Researchers will first determine safe dosage levels, then expand to study how the drug behaves in the body and whether it helps…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC